Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (unaudited)

v3.21.2
Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jul. 03, 2021
Jun. 27, 2020
Cash flows from operating activities:    
Net income (loss) $ 53,282 $ (4,315)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 28,142 17,021
Goodwill impairment   31,871
Stock-based compensation expense 4,183 2,447
Amortization of debt issuance costs 249 358
Provision (benefit) for deferred income taxes 3,249 (2,370)
Forward contract gains, net (1,909) (41)
Other, net (173) 625
(Increase) decrease in:    
Accounts receivable (37,386) (7,040)
Inventories (22,917) (724)
Income taxes receivable (808) 327
Other current assets (2,247) (1,736)
Other assets 2,921 1,855
Increase (decrease) in:    
Accounts payable 15,530 (18)
Accrued expenses and other liabilities 6,058 (1,424)
Income taxes payable 5,284 4,885
Other noncurrent liabilities (3,925) (1,390)
Net cash provided by operating activities 49,533 40,331
Cash flows from investing activities:    
Acquisition of a business, net of cash acquired (1,000)  
Amounts paid for net assets acquired (2,400)  
Capital expenditures (10,305) (5,215)
Proceeds from dispositions of equipment 62 67
Cash settlement of forward contracts 947 (357)
Software development costs (1,490)  
Net cash used in investing activities (14,186) (5,505)
Cash flows from financing activities:    
Borrowings on revolving credit facilities 9,602 11,000
Repayment of borrowings on revolving credit facilities (23,500) (26,359)
Borrowings on long-term non-revolving debt   5,714
Repayment of borrowings on long-term non-revolving debt (8,163) (4,001)
Proceeds from stock issued 814 723
Dividends to shareholders (5,791) (5,772)
Other financing activities (1,686) (960)
Net cash used in financing activities (28,724) (19,655)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 2,532 (331)
Net increase in cash, cash equivalents and restricted cash 9,155 14,840
Cash, cash equivalents and restricted cash, beginning of period 25,257 22,162
Cash, cash equivalents and restricted cash, end of period $ 34,412 $ 37,002